About 5 results found for searched term "SN52" (0.056 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3989 | Vosaroxin | Topoisomerase |
| SNS-595,AG 7352; Voreloxin | ||
| Vosaroxin is a novel first-in-class quinolone derivative that has been developed for use in the treatment of AML as a new-generation topo II inhibitor. | ||
| M8683 | Vosaroxin hydrochloride | Topoisomerase |
| SNS-595 Hydrochloride; Vosaroxin Hydrochloride; AG 7352 Hydrochloride; Voreloxin Hydrochloride | ||
| Vosaroxin hydrochloride is a novel quinolone derivative and first-in-class topoisomerase II inhibitor for AML-related studies. | ||
| M24957 | Axatilimab | CSF-1R (c-Fms) |
| SNDX-6352 | ||
| Axatilimab (SNDX-6352) is a humanized IgG4 antibody with high affinity to CSF-1R. Axatilimab can be used for the research of chronic graft versus host disease (cGVHD) and neoplastic diseases. | ||
| M25407 | SN52 | NF-κB |
| SN-52 | ||
| SN52 is a novel potent, competitive, and cell-permeable inhibitor of nuclear factor-kappaB (NF-κB). SN52 is a variant of the SN50 peptide and inhibits the nuclear translocation of p52-RelB heterodimers. SN52 has a strong radiosensitization effect on prostate cancer cells. | ||
| M49897 | SNV1521 | PARP |
| SNV1521 is a potential best-in-class (BIC), highly selective and CNS-permeable PARP1 inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
